project id: TCGA-OV; case submitter id: TCGA-59-2351; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.3; spectrophotometer method: UV Spec; age at index: 51; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1948; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3532.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 1999; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.8; longest dimension: 2.0; preservation method: Unknown; shortest dimension: 0.4; sample id: 5de10a41-af67-4417-9152-54a184a37f68; sample submitter id: TCGA-59-2351-01A; portion id: 4691ea59-038f-48b4-8b0c-01793ed5cb78; portion submitter id: TCGA-59-2351-01A-01; percent necrosis: 1.0; percent normal cells: 1.0; percent stromal cells: 19.0; percent tumor cells: 79.0; percent tumor nuclei: 80.0;